about
sameAs
Prophylactic antibiotics or G(M)-CSF for the prevention of infections and improvement of survival in cancer patients receiving myelotoxic chemotherapyFirst-line tandem high-dose chemotherapy and autologous stem cell transplantation versus single high-dose chemotherapy and autologous stem cell transplantation in multiple myeloma, a systematic review of controlled studiesAntibiotics plus colony stimulating factors versus antibiotics alone for the prevention of infections in cancer patients receiving myelosuppressive chemotherapy or haematopoetic stem cell transplantationErythropoietin or darbepoetin for patients with cancerAntiviral agents for prophylaxis of herpesviridae infections in patients with haematological malignanciesQ24235340Antibiotics plus colony stimulating factors versus antibiotics alone for the prevention of infections in cancer patients receiving myelosuppressive chemotherapy or haematopoetic stem cell transplantationAutologous stem cell transplantation vs chemotherapy in adult acute lymphocytic leukaemiaChemotherapy alone versus chemotherapy plus radiotherapy for early stage Hodgkin lymphomaErythropoietin or Darbepoetin for patients with cancer - meta-analysis based on individual patient dataGranulopoiesis-stimulating factors to prevent adverse effects in the treatment of malignant lymphomaAntibiotics plus colony stimulating factors versus antibiotics alone for the prevention of infections in cancer patients receiving myelosuppressive chemotherapy or haematopoetic stem cell transplantationProphylactic antibiotics or G-CSF for the prevention of infections and improvement of survival in cancer patients undergoing chemotherapyAntibiotics plus colony stimulating factors versus CSFs alone and antibiotics plus CSFs versus no prophylaxis for the prevention of infections in cancer patients receiving myelosuppressive chemotherapy or haematopoetic stem cell transplantationAntiviral agents for prophylaxis of herpesviridae infections in patients with haematological malignanciesCorticosteroids for preventing graft-versus-host disease after allogeneic myeloablative stem cell transplantationHigh-dose chemotherapy with autologous stem cell transplantation in the first line treatment of aggressive Non-Hodgkin Lymphoma (NHL) in adultsHigh-dose chemotherapy with autologous stem cell support for first-line treatment of aggressive non-Hodgkin lymphoma: a systematic review and meta-analysis based on individual patient dataAutologous stem cell transplantation vs chemotherapy in adult acute lymphocytic leukaemiaErythropoietin or Darbepoetin for patients with cancer - meta-analysis based on individual patient dataChemotherapy plus Rituximab versus chemotherapy alone for B-cell non-Hodgkin's lymphomaFirst-line stem cell transplantation from related donors compared to immunosuppressive treatment for acquired severe aplastic anaemiaChemotherapy alone versus chemotherapy plus radiotherapy for early stage Hodgkin LymphomaFirst-line double high-dose chemotherapy and autologous stem cell transplantation versus single high-dose chemotherapy and autologous stem cell transplantation in multiple myelomaProphylactic antibiotics and G-CSF for the prevention of infections and improvement of survival in cancer patients undergoing chemotherapyPurine Antagonists for Chronic Lymphocytic LeukaemiaErythropoietin or Darbepoetin for patients with cancerThe erythropoietin receptor in normal and cancer tissuesIs human herpesvirus 8 infection more common in men than in women? Systematic review and meta-analysis.Pitfalls of practicing cancer epidemiology in resource-limited settings: the case of survival and loss to follow-up after a diagnosis of Kaposi's sarcoma in five countries across sub-Saharan AfricaEffects of erythropoiesis-stimulating agents on fatigue- and anaemia-related symptoms in cancer patients: systematic review and meta-analyses of published and unpublished dataCombined modality treatment improves tumor control and overall survival in patients with early stage Hodgkin's lymphoma: a systematic review.Effectiveness of erythropoietin in the treatment of patients with malignancies: methods and preliminary results of a Cochrane review.Impact of granulocyte colony-stimulating factor (CSF) and granulocyte-macrophage CSF in patients with malignant lymphoma: a systematic review.Recombinant human erythropoietin and overall survival in cancer patients: results of a comprehensive meta-analysis.Recombinant human erythropoietins and cancer patients: updated meta-analysis of 57 studies including 9353 patients.Single-agent purine analogues for the treatment of chronic lymphocytic leukaemia: a systematic review and meta-analysis.High-dose chemotherapy with autologous stem cell support in first-line treatment of aggressive non-Hodgkin lymphoma - results of a comprehensive meta-analysis.Use of epoetin and darbepoetin in patients with cancer: 2007 American Society of Hematology/American Society of Clinical Oncology clinical practice guideline update.Use of epoetin and darbepoetin in patients with cancer: 2007 American Society of Clinical Oncology/American Society of Hematology clinical practice guideline update.
P50
Q24187043-91651431-13CD-4578-90DA-2F25B218C234Q24197999-36937E28-1D70-463E-A242-B97AB5BF8449Q24200225-14DEF9E5-4F84-4179-9FFF-B6616E407001Q24202335-1EF39726-A36E-46C3-A9DE-16532352F4E4Q24234350-1456A2D1-6B8A-471E-8CDE-0B8DA9BB0EA2Q24235340-23B258CD-8BDA-490C-88FA-073A9F4409EDQ24235345-50E9AB71-06CB-48EA-9DBD-3441921E51C7Q24235485-D69D9047-419D-4077-B60E-C2FE5E43ED39Q24236589-BFEB6DA7-DDA5-4688-A8D8-038A368CF5F4Q24240202-49D54595-F849-4D95-B610-D7C95EAC4884Q24240753-61C2D9B5-9848-4BE8-9B97-CB400F8985BFQ24241475-35139E24-3166-45C7-9FAA-7382FC754CEDQ24241680-D8C34DE3-1163-4CEB-A488-A7DA9F07FACCQ24241689-2BCAFA49-2AD8-4151-8E01-33E38166B262Q24241918-85CAF539-6C09-4020-AE91-A22EA474A569Q24241965-7F876E01-20D4-4E07-99F9-6669DDE9474FQ24242089-7AE091A8-0E79-43E1-AEDC-2E16EAC46178Q24242447-1B7AE4A6-7674-403C-9719-28EEC329FFAAQ24242466-B03B09B5-6057-4EF4-8543-82D0496B32C9Q24242864-7E0FA9E6-9D17-412C-A059-FCF2DEE667C2Q24243100-59836729-D843-4B48-A5F1-0A159EE850B0Q24243326-F7E9542F-2104-44FF-BBD4-3C47EA330FA1Q24243379-FEF046D9-8CC5-4C04-A6ED-B8A5D3C19E85Q24243542-97710035-0E70-457C-8940-53AD3D78C8FAQ24243543-7DED4929-B8E7-4CF5-8FD9-33220B16E004Q24245132-51500926-C263-4314-A81C-0AF981DA1B2BQ24245464-FAF1AC30-0AA6-4183-A47F-49006E2C705EQ28277629-5B96B246-7DFA-444A-9080-5DA0BC9ADF69Q30251620-0F20E7A9-582A-40F4-8FAF-7DB3FA9BA374Q30386031-DE31CB50-8984-4E34-A390-8157F117C556Q30803363-352D88BF-C930-4557-9F88-33391EA37C38Q30937299-1838769A-1A55-4F98-906B-264707824671Q31156579-DEB40F47-8D2B-4CE1-84C3-66D361DACAB1Q33187849-060E25CB-E602-413F-A41E-CBBF3DF143DBQ33213775-3FAADF94-D0BA-4171-82E8-588B5A9FD120Q33243661-AEFCBC35-76D9-4FE4-8104-ED1F146A1A45Q33247660-AD043CCC-6D0B-4E72-B65B-A590F43EA91CQ33280731-C0BE496F-9B7A-45ED-B784-DCBECB991AAEQ33303528-FBE88145-9B72-40FA-8217-CDB9D3F82C2BQ33303530-47F2627B-0C09-4DC7-A6FE-AA9C49574ADC
P50
description
hulumtuese
@sq
onderzoeker
@nl
researcher
@en
հետազոտող
@hy
name
Julia Bohlius
@ast
Julia Bohlius
@en
Julia Bohlius
@es
Julia Bohlius
@nl
Julia Bohlius
@sl
type
label
Julia Bohlius
@ast
Julia Bohlius
@en
Julia Bohlius
@es
Julia Bohlius
@nl
Julia Bohlius
@sl
prefLabel
Julia Bohlius
@ast
Julia Bohlius
@en
Julia Bohlius
@es
Julia Bohlius
@nl
Julia Bohlius
@sl
P106
P1153
6507302118
P21
P31
P496
0000-0003-1955-1585